Acclinate’s Equitable IBD Innovations
Though irritable bowel diseases (IBDs) are classically associated with White patient populations, these conditions have been on the rise in communities of color. In fact, rates of Crohn’s disease and ulcerative colitis among those who identify as Black and Hispanic increased 134% from 1970 to 2010.1
Acknowledging IBD clinical trials have often ignored these demographics, Acclinate has partnered with leading research sponsors to engage and support community members with Crohn’s and colitis.
Our Approach
Build a NOWINCLUDED gut community circle to provide gut health resources
Partner with advocacy groups and healthcare providers to engage & educate members
Curate clinical trial opportunities and gathering insights on barriers to participation in clinical trials
I was diagnosed with ulcerative colitis 12 years ago and I truly felt alone within my IBD journey. I truly appreciate hearing other patient’s stories and learning how they navigate the ups and downs of living with a chronic illness.
– NOWINCLUDED community member
Our Initial Results
Since January of 2023, Acclinate has reached over 1.5M community members through NOWINCLUDED’s gut health community circle initiatives.
1.5M+
people reached with general gut health and IBD education
47.9K+
members engaged through our omnichannel approach
660+
in-depth surveys collected from community members
150+
personal stories filmed through NOWINCLUDED
11K+
members offered opportunity to participate in IBD research
200+
completed pre-screeners for IBD research
Notable Findings
The NOWINCLUDED community was also polled about their outlook on IBD
research trials.
of respondents would be willing to participate in IBD research
reported they might be willing to participate in IBD research
reported previously participating in a clinical trial
cited difficulty finding the right doctor as a key barrier to care
rely on their primary care provider for health management resources
Learn More About Acclinate’s Mission and Model
Acclinate has built a network of community activation points and a dynamic digital health platform to mobilize health equity at scale. Our industry-leading products leverage predictive analytics and AI to make existing trials more representative and plan more inclusive studies moving forward. For a deeper dive into how Acclinate is empowering communities to advance equity across healthcare,
schedule a call with our team.
Girl Talk: What in the Guts?!
Watch our gut health community ambassadors Deanna and LaTanja spill the tea on life with IBD during our
Girl Talk: What in the Guts?! listening party.
References
1. https://www.jnj.com/innovation/meet-innovators-combatting-rise-inflammatory-bowel-disease-communities-of-color
